2002
DOI: 10.1038/nrd915
|View full text |Cite
|
Sign up to set email alerts
|

Putting chirality to work: the strategy of chiral switches

Abstract: Most of the new drugs reaching the market today are single enantiomers, rather than the racemic mixtures that dominated up to ten years ago. Many of the new single-enantiomer drugs were developed as such, but there are also important examples of new single-enantiomer drugs derived from 'chiral switches' of established racemates. Indeed, a well-timed chiral switch can offer enhanced therapy and further profitability as a 'line extension' of a major racemic drug with patents that are expiring.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
451
0
29

Year Published

2005
2005
2021
2021

Publication Types

Select...
5
4
1

Relationship

0
10

Authors

Journals

citations
Cited by 558 publications
(482 citation statements)
references
References 50 publications
2
451
0
29
Order By: Relevance
“…Considerable differences in the toxicological, pharmacological, or pharmacokinetic properties of individual enantiomers also highlight the importance of assessing the stereochemical purity of a compound in the cosmetic and fragrance industries and environmental analysis. In an effort to eliminate potential toxic side effects, most approved new chiral chemicals are marketed worldwide as singleenantiomer drugs rather than as racemates [4]. Thus, as a consequence of policies of the Food and Drug Administration (FDA), accurate determination of enantiomeric composition and purity is necessary for production of drugs containing only the therapeutically active enantiomers, which requires sensitive and accurate analytical techniques [5].…”
Section: Introductionmentioning
confidence: 99%
“…Considerable differences in the toxicological, pharmacological, or pharmacokinetic properties of individual enantiomers also highlight the importance of assessing the stereochemical purity of a compound in the cosmetic and fragrance industries and environmental analysis. In an effort to eliminate potential toxic side effects, most approved new chiral chemicals are marketed worldwide as singleenantiomer drugs rather than as racemates [4]. Thus, as a consequence of policies of the Food and Drug Administration (FDA), accurate determination of enantiomeric composition and purity is necessary for production of drugs containing only the therapeutically active enantiomers, which requires sensitive and accurate analytical techniques [5].…”
Section: Introductionmentioning
confidence: 99%
“…Its implications in biochemistry are far reaching since most biomaterials exhibit predominance for a single enantiomer. Hence the importance of the synthesis and separation of pure enantiomers has been well recognized [2]. Heterogeneous catalytic processes for enantioselective synthesis have important advantages over conventional homogeneous ones [3].…”
mentioning
confidence: 99%
“…Clinical tests indicate that the replacement of racemate by a single active enantiomer of pharmaceutical allows to use of lower doses of drugs, increasing the therapeutic efficacy of individual doses. It helps to avoid possible harmful interactions with other drugs, to minimize the differences in drug metabolism between species and reduce the toxicity caused by supplementation of inactive isomers (Agranat et al, 2002;Baumann et al, 2002). There has been a trend towards to ensure that pharmaceuticals that were invented, approved and marketed as a racemate or a mixture of diastereomers, have been re-marketed as single enantiomers.…”
Section: Introductionmentioning
confidence: 99%